Debt to EBITDA ratio Analysis of Onconova Therapeutics Inc - Deep Dive
WARN : Please note that some of the values may not be in base currency

Debt to EBITDA of ONTX
Dec-23
167344
Very Poor Debt to EBITDA
Dec-22
0
Excellent Debt to EBITDA
Growth
0
%
Debt to EBITDA Analysis of Onconova Therapeutics Inc
Debt to EBITDA Ratio of Onconova Therapeutics Inc with value of 167344 shows that the company is financially distressed and does not has enough profit to pay off its debt.
Debt to EBITDA Ratio of ONTX has grown by 0 % Compared to previous Financial Year.
Debt to EBITDA Ratio with value of 167344 was highest in Year Dec-23 in last Five Years.
Debt to EBITDA Ratio with value of 0 was lowest in Year Dec-22 in last Five Years.
Latest Debt to EBITDA Ratio with value of 167344 is Greater than Average Debt to EBITDA of 33468.83 in last five years.
Other Debt to EBITDA Related Info of ONTX that may interest you.
Onconova Therapeutics Inc Overview
CodePricePrevious PricePrice ChangeSector
ONTX0.99531.0 0.470 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization.    more ..
Debt to EBITDA Formula
Debt to EBITDA Related Ratios
CashFlowFromOperationToDebtDebtToCapitalEVToEBITDA
Tsr Stability Index
Poor Stability Stock
FY - Historical Debt to EBITDA of Onconova Therapeutics Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
Debt to EBITDA1673440000-0.2020
Change0 %0 %
You are view first 7 Records. Log in to view all 13 in Premium view
FY Chart of Debt to EBITDA of Onconova Therapeutics Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)